ELAVL1 and Familial prostate cancer: Cytoplasmic HuR expression has been implicated in the malignancy of colon, ovarian, breast, salivary gland, uterine, larynx and prostate cancers and has been postulated to contribute to the cancerous malignant phenotype (21–25).